PROGRAMME | 30th Congress of the European Association of Tissue and Cell Banks

ROOM A

11.30 - 13.00

Workshop 1 – Donor evaluation

13.00 - 13.10

Opening

13.10 - 15.30

Session 1 - Donation strategies in Tissue and Cell Banking
Chairpersons: Diletta Trojan, Iwona Grabska-Liberek, Artur Kamiński

13.10 - 13.40

Ethical and legal issues of tissues and cells donation in Europe
Magdalena Kramska, MoH, Poland

13.40 - 14.30

Tissue and Cell Banking in the COVID-19 era-
oral presentatios

13.40 - 13.48

Impact of Sars-CoV-2 pandemic on the Veneto Region multitissue bank activity - Giulia Montagner

13.48 - 13.56

Own Experience with E-learning in the COVID –19 Pandemic Academic Years - Pavel Měřička

13.56 - 14.04

Increased use of cyopreservation techniques in the haematopoietic progenitor cell transplantation programme as the result of COVID-19 pandemic - Pavel Měřička

14.04 - 14.12

The impact of SARS-CoV2 pandemic on cornea donor eligibility, procurement and transplantation program in Croatia
Elizabeta Zaplatić

14.12 - 14.20

CAnalysis of post-mortem SARS-CoV2 positive donors in Croatia
Dolores Bukulin

14.20 - 14.28

Corneal banking in Warsaw Eye Bank during the Covid pandemic
Iwona Grabska – Liberek

14.28 - 14.40

Discussion

14.40 - 15.00

Coffee break

15.00 - 16.00

Session 2 – EDQdM T&C Guie
Guide to the quality and safety of tissues and cells for human application
Mar Lomero, EDQM, CoE
Chairpersons: Mar Lomero, Izabela Uhrynowska-Tyszkiewicz

16.00 - 16.20

Coffee break

16.20 - 18.00

General Session 3 – Approach to stem cells therapies
Chairpersons: Jacinto Sanchez Ibanez, Dariusz Śladowski

16.20 - 16.40

Innovation under the new BTC legal framework
Stefaan van der Spiegel, EC

16.40 - 17.4=00

Stem cells donor protection in Europe
Dr Jacinto Sanchez Ibanez, MD, PhD, Spain

17.00 - 17.20

HSCs in non-haematological therapies
Assoc. Prof. Emilian Snarski, MD PhD, Poland

17.20 - 17.40

HE-ATMP controversies
Assoc. Prof. Dariusz Śladowski, MD, PhD, Poland, CAT, EMA

17.40 - 18.00

Tissue and Cell Bank co-operation with ATMP manufacturers
Dr Izabela Uhrynowska-Tyszkiewicz, MD, PhD, Poland

20:00

Welcome reception

ROOM A

08.30 - 10.30

Workshop 2 – Microbiological risk assessment tool

10.30 - 11.00

Coffee break

11.00 - 13.00

Session 4 – Ocular tissues
Chairpersons: Diego Ponzin, Martin Börgel

11.00 - 11.30

Limbal cells in ocular treatment
Dr Diego Ponzin, Italy

11.30 - 11.38

How long does it take to detect germs in corneal rims culture ?
a single-center ten-year retrospective study - Xavier Lafarge

11.38 - 11.46

Challenges for corneal donation: Securing patient care in the future
Nicola Hofmann

11.46 - 11.54

Advancing corneal health: Indo-German cooperation enhancing eye donation
in North India - Anna-Katharina Salz

11.54 - 12.02

International eligibility criteria for corneal donation by men who have sex with men - Michael Puente

12.02 - 12.10

Bands of freeze-dried human amniotic membrane of umbilical cord (hAM-UC)
as substitute for sclera graft in wrapping of orbital implant - Laurence Barnouin

12.10 - 12.18

Use of freeze-dried human amniotic membrane of umbilical cord (hAM-UC) as scleral patch graft for treatment of
tumor of the conjunctiva - Laurence Barnouin

12.18 - 12.30

Discussion

12.30 - 13.40

Session 5 – Skin & Nerve
Chairpersons: Richard Lomas, Wojciech Łabuś

12.30 - 13.00

Skin decellularisation techniques
Wojciech Łabuś, Ph.D., Poland

13.00 - 13.08

Validation of a decellularization method of human dermis
Giulia Montagner

13.08 - 13.16

Dermal CellSpray - the influence of different nozzle types on cell viability
and spray formation - Miriam Heuer

13.16 - 13.24

The use of amniotic membrane in the treatment of facial burns
Agnieszka Klama-Baryła

13.24 - 13.32

Processed inverted human umbilical vessel as nerve regeneration conduit
in the treatment of hand nerve section - Laurence Barnouin

13.32 - 13.40

Discussion

13.40 - 14.30

Lunch

14.30 - 16.00

Session 6 – Cardiovascular tissues
Chairpersons: Ramadan Jashari, Mariusz Birbach

14.30 - 15.00

The past, the present and the future of the cardio-vascular tissue transplantation
Ramadan Jashari, MD, PhD, Belgium

15.30 - 15.38

Cryopreserved allogeneic pericardium — the use in congenital heart defects
repair in children - Mariusz Birbach

15.38 - 15.46

40 years of allograft heart valve banking in the Czech Republic
Jan Burkert

15.46 - 15.54

CAllograft heart valves allocation & delivery system in the Czech Republic
Gabriela Hribalova

15.54 - 16.02

A 28-years experience with cryopreserved aortic homograft utilization in patients with complex aortic valve or root endocarditis Giulia Montagner

16.02 - 16.30

Discussion

16.30 - 17.00

Coffee break

17.00 - 18.30

Workshop 3 – Quality and safety

20:00

Gala Dinner

[/schedule] [/tabs_item]

11.00 - 13.00

Session 4 – Oscular tissues

11.00 - 11.30

Limbal cells in ocular treatment,
Dr Diego Ponzin, Italy

11.30 - 12.30

o ral presentations

12.30 - 13.30

 Session 5 – Skin & Nerve

12.30 - 13.00

Skin decellularisation techniques
Wojciech Łabuś, Ph.D., Poland

13.00 - 13.30

oral presentations

16.00 - 16.30

Discussion

16.30 - 17.00

Lunch

17.00 - 18.30

Parallel Session 6 – Cardiovascular

17.00 - 17.30

The past, the present and the future of the cardio-vascular tissue transplantation
Dr Ramadan Jashari, Belgium

17.30 - 18.30

4 oral presentations

[/tabs]

ROOM A

08.30 - 10.30

Workshop 4 – Novelty assessing tools (GAPP project)

10.30 - 11.00

Coffee break

11.00 - 13.30

Session 7 – Musculoskeletl tissues
Chairpersons: Jaime Tabera Fernandez, Branka Golubić Ćepulić

11.00 - 11.20

Reconstruction of alveolar bone with tissue allografts
Assoc. Prof. Kornel Krasny, DDS, PhD

11.20 - 11.28

Role of the tissue establishment with the autologous bone flap. our experience in the last 20 years - Jacinto Sanchez Ibañez

11.28 - 11.36

Evaluation of different defatting procedures on bone properties
Michał Srebrzyński

11.36 - 11.44

Impact of five years experience in human femoral head collection program from living donors on microbiological contamination in University Hospital Centre Zagreb - Ivana Vidović

11.44 - 11.52

Tendon allograft needs. How is the situation evolving?
Olivier Cornu

11.52 - 12.00

Enhancement of the healing of the ruptured Achilles tendon with the use of scafolds with ADCSs and GDF-7 local injections in a rabbit model - Artur Kamiński

12.00 - 12.08

Whether the ADSC cells administered in the area of the iatrogenic rupture have only a paracrine effect? - Grzegorz Gut

12.08 - 12.16

The influence of stem cells and / or cytokines delivery on the healing process of the iatrogenic tendon rupture - Grzegorz Gut

12.16 - 12.24

Biomechanical effects on the long-term storage of tendon allografts
Volker Eras

12.24 - 12.32

Meniscal allografts: where do we stand? - Olivier Cornu

12.32 - 12.40

Human amniotic membrane potential for bone repair: from the lab to the clinic - Florelle Gindraux

12.40 - 13.00

Discussion

13.00 - 14.00

Session 8 – Varia
Chairpersons: Pavel Měřička, Grzegorz Gut

13.00 - 13.08

Regulatory and quality aspects of innovative therapeutic options derived from perinatal derivatives - Nicola Hofmann

13.08 - 13.16

International Tissue Banking & Advanced Therapies educational
program (2003-2022) - Estephan Arredondo

13.16 - 13.24

70 years of the Tissue Bank University Hospital Hradec Králové
from the past to future perspectives - Pavel Měřička

13.24 - 13.32

Ongoing changes in the structure of tissue procurement in Poland
new logistic challenges - Izabela Uhrynowska-Tyszkiewicz

13.32 - 13.40

MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent
a Robust Model for Melanoma in Pregnancy - Beate Rinner

13.40 - 13.48

Short and long term patient-derived sarcoma models – to study the variety of soft-tissue tumors - Beate Rinner

13.48 - 14.00

Discussion

14.00

Closing and Awards